$2.43 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 64 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 21.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Sell | BIOGEN IDEC INC | $164,067,000 | +7.8% | 536,393 | -1.5% | 6.75% | +2.8% |
| CELG | Sell | CELGENE CORP | $79,047,000 | -33.8% | 566,236 | -19.8% | 3.25% | -36.8% |
| AGN | Sell | ALLERGAN INC | $61,622,000 | -1.2% | 496,548 | -11.5% | 2.54% | -5.7% |
| B108PS | Sell | ACTAVIS PLC | $60,510,000 | +17.3% | 293,950 | -4.3% | 2.49% | +11.9% |
| SHPG | Sell | SHIRE PLCsp adr | $58,104,000 | -12.3% | 391,197 | -16.5% | 2.39% | -16.3% |
| THRX | Sell | THERAVANCE INC | $57,273,000 | -18.6% | 1,851,088 | -6.2% | 2.36% | -22.3% |
| IRWD | Sell | IRONWOOD PHARMACEUCL | $57,192,000 | -3.1% | 4,642,182 | -8.7% | 2.35% | -7.6% |
| P103PS | Sell | NPS PHARMACEUTICALS | $42,163,000 | -21.8% | 1,408,729 | -20.6% | 1.73% | -25.4% |
| GEVA | Sell | SYNAGEVA BIOPHARMA | $38,593,000 | -19.3% | 465,145 | -37.1% | 1.59% | -23.1% |
| ISIS | Sell | ISIS PHARMACEUTICALS | $38,116,000 | -21.7% | 882,101 | -27.8% | 1.57% | -25.3% |
| MRK | Sell | MERCK & CO INC | $37,896,000 | -30.8% | 667,537 | -39.0% | 1.56% | -34.0% |
| MNKKQ | Sell | MALLINCKRODT PLC | $28,710,000 | +20.9% | 452,764 | -0.4% | 1.18% | +15.3% |
| CLDX | Sell | CELLDEX THERAPEUTICS | $24,895,000 | -53.8% | 1,408,908 | -36.8% | 1.02% | -56.0% |
| INSM | Sell | INSMED INC | $22,317,000 | -12.0% | 1,172,121 | -21.4% | 0.92% | -16.1% |
| RDY | Sell | DR REDDYS LABS LTDadr | $18,948,000 | +6.4% | 431,612 | -0.6% | 0.78% | +1.4% |
| AKRXQ | Sell | AKORN INC | $16,752,000 | -23.3% | 761,443 | -14.2% | 0.69% | -26.9% |
| F113PS | Sell | COVIDIEN PLC | $15,459,000 | -37.4% | 209,876 | -42.1% | 0.64% | -40.3% |
| ISRG | Sell | INTUITIVE SURGIC INC | $14,194,000 | -43.8% | 32,408 | -50.7% | 0.58% | -46.4% |
| ABBV | Sell | ABBVIE INC | $14,083,000 | -43.6% | 273,979 | -42.0% | 0.58% | -46.2% |
| BSX | Sell | BOSTON SCIENTIFIC | $13,780,000 | -45.4% | 1,019,221 | -51.5% | 0.57% | -47.9% |
| ALGN | Sell | ALIGN TECH INC | $10,206,000 | -44.4% | 197,072 | -38.6% | 0.42% | -46.9% |
| TRNX | Sell | TORNIER N Vordinar | $9,396,000 | -12.8% | 442,801 | -22.8% | 0.39% | -17.0% |
| HTWR | Sell | HEARTWARE INTL INC | $9,307,000 | -40.2% | 99,241 | -40.1% | 0.38% | -42.9% |
| NXTM | Sell | NXSTAGE MEDICAL | $6,325,000 | -16.0% | 496,465 | -34.1% | 0.26% | -20.0% |
| ARAY | Sell | ACCURAY INC | $4,644,000 | -38.5% | 483,739 | -44.3% | 0.19% | -41.4% |
| DXCM | Sell | DEXCOM INC | $2,951,000 | -48.0% | 71,346 | -55.5% | 0.12% | -50.6% |
| XLRN | Exit | ACCELERON PHARMA | $0 | – | -9,827 | -100.0% | -0.02% | – |
| KPTI | Exit | KARYOPHARM THERAPE | $0 | – | -35,000 | -100.0% | -0.04% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -50,000 | -100.0% | -0.05% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -239,485 | -100.0% | -0.23% | – |
| PCYC | Exit | PHARMACYCLICS INC | $0 | – | -168,425 | -100.0% | -0.77% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -388,760 | -100.0% | -1.07% | – |
| PRGO | Exit | PERRIGO CO | $0 | – | -327,268 | -100.0% | -2.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.